Steven A. Ledger - 09 Sep 2024 Form 4 Insider Report for Serina Therapeutics, Inc. (SER)

Role
Chief Executive Officer, Director
Signature
/s/ Steven Ledger
Issuer symbol
SER
Transactions as of
09 Sep 2024
Net transactions value
$0
Form type
4
Filing time
11 Sep 2024, 16:30:26 UTC
Previous filing
03 Apr 2024
Next filing
01 Apr 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Award $0 +376,388 +330% $0.000000 490,350 09 Sep 2024 Common Stock 376,388 $7.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest as to 12.5% of the underlying shares on March 9, 2025 and thereafter in substantially equal monthly installments such that the stock options shall be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.